Search details
1.
Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2.
Cancer Immunol Immunother
; 65(8): 941-9, 2016 08.
Article
in English
| MEDLINE | ID: mdl-27277816
2.
Limited genomic heterogeneity of circulating melanoma cells in advanced stage patients.
Phys Biol
; 12(1): 016008, 2015 Jan 09.
Article
in English
| MEDLINE | ID: mdl-25574741
3.
A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma.
Invest New Drugs
; 29(3): 489-98, 2011 Jun.
Article
in English
| MEDLINE | ID: mdl-20082117
4.
A nonpeptidyl mimic of superoxide dismutase, M40403, inhibits dose-limiting hypotension associated with interleukin-2 and increases its antitumor effects.
Nat Med
; 9(6): 750-5, 2003 Jun.
Article
in English
| MEDLINE | ID: mdl-12730689
5.
Management of renal cancer in the tyrosine kinase inhibitor era: a view from 3 years on.
BJU Int
; 102(2): 162-5, 2008 Jul.
Article
in English
| MEDLINE | ID: mdl-18410430
6.
N-acetylcysteine protects melanocytes against oxidative stress/damage and delays onset of ultraviolet-induced melanoma in mice.
Clin Cancer Res
; 13(19): 5952-8, 2007 Oct 01.
Article
in English
| MEDLINE | ID: mdl-17908992
7.
Emerging drugs for the treatment of metastatic renal cancer.
Expert Opin Emerg Drugs
; 12(4): 605-18, 2007 Nov.
Article
in English
| MEDLINE | ID: mdl-17979602
8.
High frequency of brain metastases after adjuvant therapy for high-risk melanoma.
Cancer Med
; 6(11): 2576-2585, 2017 Nov.
Article
in English
| MEDLINE | ID: mdl-28994212
9.
Population-based prevalence of CDKN2A mutations in Utah melanoma families.
J Invest Dermatol
; 126(3): 660-6, 2006 Mar.
Article
in English
| MEDLINE | ID: mdl-16397522
10.
Evaluation of a 7-day continuous intravenous infusion of decitabine: inhibition of promoter-specific and global genomic DNA methylation.
J Clin Oncol
; 23(17): 3897-905, 2005 Jun 10.
Article
in English
| MEDLINE | ID: mdl-15753459
11.
Population-based analysis of prognostic factors and survival in familial melanoma.
J Clin Oncol
; 23(28): 7168-77, 2005 Oct 01.
Article
in English
| MEDLINE | ID: mdl-16192601
12.
Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2.
Ecancermedicalscience
; 10: 676, 2016.
Article
in English
| MEDLINE | ID: mdl-27729941
13.
Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant.
J Clin Oncol
; 21(11): 2179-86, 2003 Jun 01.
Article
in English
| MEDLINE | ID: mdl-12775744
14.
Longitudinal assessment of the nevus phenotype in a melanoma kindred.
J Invest Dermatol
; 123(3): 576-82, 2004 Sep.
Article
in English
| MEDLINE | ID: mdl-15304099
15.
Suppression of cytokine-inducible nitric oxide synthesis during intraperitoneal meth a tumor growth.
J Vet Med Sci
; 66(4): 357-65, 2004 Apr.
Article
in English
| MEDLINE | ID: mdl-15133264
16.
Suppression of cytokine-inducible nitric oxide synthesis during intraperitoneal Meth A tumor growth.
J Vet Med Sci
; 66(5): 357-65, 2004 May.
Article
in English
| MEDLINE | ID: mdl-15198099
17.
A phase I, open-label study of trebananib combined with sorafenib or sunitinib in patients with advanced renal cell carcinoma.
Clin Genitourin Cancer
; 12(3): 167-177.e2, 2014 Jun.
Article
in English
| MEDLINE | ID: mdl-24365125
18.
Recent advances in the understanding of the genetics, etiology, and treatment of Merkel cell carcinoma.
Semin Oncol
; 39(2): 163-72, 2012 Apr.
Article
in English
| MEDLINE | ID: mdl-22484188
19.
Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
J Clin Oncol
; 30(1): 88-109, 2012 Jan 01.
Article
in English
| MEDLINE | ID: mdl-22147736
20.
Management of melanoma brain metastases in the era of targeted therapy.
J Skin Cancer
; 2011: 845863, 2011.
Article
in English
| MEDLINE | ID: mdl-22220282